KINS
菌と生きる。体が生きる。
Tokyo, Japan · Founded 2018 · $23.6M raised
- Headquarters
- Tokyo
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B2C
- Website
- yourkins.com
- Total Funding
- $23.6M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
KINS is a Tokyo-based microbiome healthcare company founded in December 2018 by Dr. Yutaka Shimokawa. The company offers D2C supplements and skincare products for gut, skin, and scalp health, along with a subscription concierge service for personalized health advice via LINE. KINS also operates veterinary hospitals in Japan and a human-focused clinic in Singapore, while its in-house KINS LAB conducts R&D using a proprietary bacteria bank of over 20,000 samples to develop microbiome-based products for B2B clients in food, cosmetics, and pharmaceuticals. The company has expanded to Taiwan and Singapore with the long-term goal of developing microbiome-based pharmaceuticals.
Summary
KINS is a Biotech company based in Tokyo, Japan, founded in 2018. It has raised $23.6M in total across 1 round. Investors include Awagin Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kins"><img src="https://indexed.vc/api/badge/company/kins" alt="KINS on Indexed.vc" width="260" height="76" /></a>